Ivabradine: a SHIFT in heart failure management

Abstract

This article outlines the use of ivabradine as a pharmacological approach in chronic heart failure. Ivabradine is a specific heart-rate reducing agent that is proven to be effective in symptomatic heart failure. This article looks at the benefits of adding ivabradine to standard heart failure therapy, as well as its indications, contraindications and side effects, and explains the underlying pathophysiology and pharmacokinetics. It also provides guidance on safe management and monitoring of patients on ivabradine by explaining the responsibilities of the nurse prescriber or prescribing physician. Information needed for patient counselling is also covered in this article.